This high risk/high reward biotech is at the busness end of proceedings after many years of development. If in 18months or so we are successful in getting FDA approval the returns could be huge. I now am too frightened to trade the stock as I may miss the boat on its potential. I will just have to try very hard and remain disciplined to keep at least a core holding during the coundown to the final outcome.
- Forums
- ASX - By Stock
- IMM
- why nasdaq
why nasdaq, page-17
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.3¢ |
Change
-0.013(3.73%) |
Mkt cap ! $421.2M |
Open | High | Low | Value | Volume |
32.0¢ | 33.0¢ | 28.0¢ | $5.141M | 16.77M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 220892 | 32.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 209498 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 256253 | 0.315 |
16 | 167268 | 0.310 |
6 | 111127 | 0.305 |
12 | 529076 | 0.300 |
5 | 127452 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 127944 | 14 |
0.325 | 271730 | 10 |
0.330 | 109189 | 7 |
0.335 | 102593 | 8 |
0.340 | 154125 | 6 |
Last trade - 13.38pm 28/06/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online